Metabolic Modeling Elucidates Phenformin and Atpenin A5 as Broad-Spectrum Antiviral Drugs

dc.contributor.author	Dräger, Andreas
dc.contributor.author	Schindler, Michael
dc.contributor.author	Renz, Alina
dc.contributor.author	Hohner, Mirjam
dc.date.accessioned	2024-05-22T09:43:02Z
dc.date.available	2024-05-22T09:43:02Z
dc.date.issued	2024-03-22
dc.identifier.uri	http://hdl.handle.net/10900/153610
dc.language.iso	en	de_DE
dc.publisher	Preprints.org	de_DE
dc.relation.uri	https://doi.org/10.20944/preprints202210.0223.v1	de_DE
dc.subject.ddc	004	de_DE
dc.title	Metabolic Modeling Elucidates Phenformin and Atpenin A5 as Broad-Spectrum Antiviral Drugs	de_DE
dc.type	Preprint	de_DE
utue.personen.roh	Dräger, Andreas
utue.personen.roh	Kaleta, Christoph
utue.personen.roh	Schindler, Michael
utue.personen.roh	Cabreiro, Filipe
utue.personen.roh	Marinos, Georgios
utue.personen.roh	Jami, Raphaël
utue.personen.roh	Best, Lena
utue.personen.roh	Dürrwald, Johanna
utue.personen.roh	Josephs-Spaulding, Jonathan
utue.personen.roh	Breitenbach, Maximilian
utue.personen.roh	Hohner, Mirjam
utue.personen.roh	Renz, Alina